VDR and prostate carcinoma: Our in vitro and in vivo studies demonstrate that the VDR has a function in promoting the growth of breast and prostate cancer cells, independent of its cognate ligand, 1,25(OH)2D. This previously unrecognized function of the VDR is operational both within and outside the bone microenvironment.